NCT04095455

Brief Summary

Background: Postoperative pain is one of the greatest patient concerns following surgery. However, general anesthesia cannot provide adequate postoperative pain control and the routine use of parenteral opioids aggravates postoperative sedation, nausea, emesis, impaired oxygenation and depressed ventilation. Hypothesis: The investigators assume that both ultrasound guided Modified Pecs Block and combination of Ketamine and Magnesium sulphate infusion can achieve better analgesia in major breast cancer surgery in the form of reducing total amount of intraoperative fentanyl requirement and reducing postoperative morphine requirement and improvement of postoperative VAS scores both at rest and during shoulder movement so we plan this study to evaluate this assumption

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P25-P50 for phase_3 postoperative-pain

Timeline
Completed

Started Nov 2017

Longer than P75 for phase_3 postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 12, 2017

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 19, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2021

Completed
Last Updated

October 27, 2020

Status Verified

October 1, 2020

Enrollment Period

3.3 years

First QC Date

June 28, 2019

Last Update Submit

October 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • total morphine requirements

    calculating the total dose of morphine consumed in postoperative analgesia

    24 hours postoperatively

Secondary Outcomes (4)

  • fentanyl consumption

    intraoperative period

  • Visual analogue scale score

    immediately after recovery and then at 1, 4, 8, 12, and 24 hours postoperatively.

  • Sedation score

    A sedation level recorded upon arrival to the PACU and at 1, 4, 8, 12, and 24 hours postoperatively.

  • Nausea and vomiting

    during the first post-operative 24 hours

Study Arms (3)

pectoral nerves block group

ACTIVE COMPARATOR

modified pectoral nerves block was performed on the side of surgery

Procedure: pectoral nerves block group

Ktamine plus Magnesium group

ACTIVE COMPARATOR

Patients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the induction of general anesthesia. This was followed by intraoperative continuous infusion of 10 mg/kg/h of magnesium sulphate combined with infusion of 0.1mg/kg/h ketamine that was started before skin incision and continued until completion of skin closure via infusion pump

Drug: Ketamine plus magnesium group

Control Group

ACTIVE COMPARATOR

Normal saline infusion with similar rate and volume to KM infusion was used as a placebo

Drug: Control group

Interventions

ultrasound guided block of nerve supply of surgical site

pectoral nerves block group

Patients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the induction of general anesthesia. This was followed by intraoperative continuous infusion of 10 mg/kg/h of magnesium sulphate combined with infusion of 0.1mg/kg/h ketamine that was started before skin incision and continued until completion of skin closure via infusion pump (Atom Syringe Pump S-1235).

Ktamine plus Magnesium group

Normal saline infusion with similar rate and volume to KM infusion was used as a placebo.

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female patients with American society of Anesthesia classification(ASA) II physical status undergoing major breast cancer surgery with axillary evacuation under general anesthesia.
  • Patients' age from18 to 65 Years.
  • Body mass index (BMI) are from 20 to 40 kg/m2.

You may not qualify if:

  • Pregnant patients
  • Patients having sensitivity or contraindication to test drugs or regional anesthesia.
  • severe respiratory or cardiac disorders.
  • history of psychological disorder.
  • chronic pain .
  • significant liver or renal insufficiency. .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Institute

Al Haram, Giza Governorate, 12555, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

KetamineControl Groups

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia and pain medicine

Study Record Dates

First Submitted

June 28, 2019

First Posted

September 19, 2019

Study Start

November 12, 2017

Primary Completion

March 11, 2021

Study Completion

April 15, 2021

Last Updated

October 27, 2020

Record last verified: 2020-10

Locations